What is the recommended dosage of gabapentin (Neurontin) for treating radiculopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gabapentin Dosing for Radiculopathy

For radiculopathy, gabapentin should be initiated at 100-300 mg at bedtime or 100-300 mg three times daily, with gradual titration up to 1800-3600 mg/day in divided doses over several weeks. 1, 2

Initial Dosing and Titration

  • Start with 100-300 mg at bedtime or 100-300 mg three times daily 3, 1
  • Increase by 100-300 mg every 1-7 days as tolerated 3, 1
  • Titrate until adequate pain relief is achieved or dose-limiting side effects occur 1
  • Maximum daily dose is 3600 mg/day in three divided doses 3, 2

Evidence for Radiculopathy

  • Studies suggest that lumbosacral radiculopathy may be relatively refractory to first-line medications compared to other neuropathic pain conditions 3
  • An open pilot study showed significant reduction in pain when gabapentin was used up to 3600 mg/day for discogenic lumbosacral radiculopathy, with better results when treatment was initiated early 4
  • In a study of 35 patients with chronic radiculopathy, gabapentin at doses up to 1800 mg/day (divided in 3 doses) significantly improved pain intensity, quality of life, and functional disability 5

Dosing Schedule

  • Day 1: 300 mg once daily
  • Day 2: 300 mg twice daily (600 mg/day)
  • Day 3: 300 mg three times daily (900 mg/day)
  • Continue titration as needed for pain relief 2
  • An adequate trial requires 3-8 weeks for titration plus 2 weeks at maximum dose 3

Efficacy Considerations

  • Clinical studies have demonstrated efficacy across a dose range of 1800-3600 mg/day 2
  • Additional benefit of using doses greater than 1800 mg/day was not consistently demonstrated in clinical studies 2
  • A recent meta-analysis found that pregabalin may be more effective than gabapentin for lumbar radiculopathy in short-term follow-up (≤6 weeks), but there was no difference in long-term follow-up (6-12 weeks) 6

Special Populations

  • For elderly patients, consider lower starting doses and slower titration due to potential decreased renal function 1, 2
  • In patients with renal impairment, dosage adjustment is necessary based on creatinine clearance 2:
    • CrCl ≥60 mL/min: 900-3600 mg/day in three divided doses
    • CrCl 30-59 mL/min: 400-1400 mg/day in two divided doses
    • CrCl 15-29 mL/min: 200-700 mg/day once daily
    • CrCl <15 mL/min: 100-300 mg/day once daily

Side Effects and Management

  • Common side effects include dizziness, somnolence, dry mouth, and constipation 3
  • Side effects can be minimized by starting with lower dosages and titrating cautiously 1
  • Maximum time between doses should not exceed 12 hours 2
  • If discontinuing gabapentin, taper gradually over a minimum of 1 week to avoid withdrawal symptoms 2

Alternative Options

  • If gabapentin is ineffective or poorly tolerated, pregabalin may be considered as an alternative 6
  • Pregabalin starting dose is 50 mg three times daily or 75 mg twice daily, with titration up to 600 mg/day 7

References

Guideline

Gabapentin Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Efficacy of gabapentin in patients with discogenic lumbosacral radiculopathy].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2009

Guideline

Pregabalin Therapy for Neuropathic Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.